It's prime time for reverse transcriptase.

Cell

Laboratory of Eukaryotic Gene Regulation, National Institutes of Child Health and Human Development, Bethesda, Maryland 20892, USA.

Published: January 1997

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0092-8674(00)81851-6DOI Listing

Publication Analysis

Top Keywords

it's prime
4
prime time
4
time reverse
4
reverse transcriptase
4
it's
1
time
1
reverse
1
transcriptase
1

Similar Publications

Background: Vaccination is one of the best ways to control the SARS-CoV-2 outbreak. In Taiwan, healthcare workers were prioritized for vaccination, but the effectiveness of these vaccines for them remains unclear. Thus, it's essential to examine their neutralizing antibodies after prime-boost vaccinations.

View Article and Find Full Text PDF

Biochar addition is effective in reducing soil greenhouse gas (GHG) emissions, but it's essential to evaluate whether aged biochar retains this capability as its properties change over time. However, research comparing the effects of fresh and aged biochar on soil GHG emissions is limited. Moreover, exploring the priming effect of biochar on native soil organic carbon (SOC) mineralization is crucial for revealing the effect mechanism on soil CO emission.

View Article and Find Full Text PDF

It's Prime Time for Primary Prevention.

Acta Cardiol Sin

September 2024

Division of Cardiology, Cardiovascular Medical Center, Far Eastern Memorial Hospital, New Taipei City.

View Article and Find Full Text PDF
Article Synopsis
  • * Nanotechnology presents a promising avenue for pain management by allowing for targeted and controlled drug delivery, which could improve the effectiveness and reduce side effects of pain relief medications.
  • * This review discusses the role of nanomaterials in drug delivery systems, exploring innovative strategies for treating pain and summarizing the latest research gathered from several reputable online libraries.
View Article and Find Full Text PDF

Background: Health and care research involving people who lack capacity to consent requires an alternative decision maker to decide whether they participate or not based on their 'presumed will'. However, this is often unknown. Advance research planning (ARP) is a process for people who anticipate periods of impaired capacity to prospectively express their preferences about research participation and identify who they wish to be involved in future decisions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!